COMPOSIZIONI FARMACEUTICHE COMPRENDENTI DERIVATI MONOSIALOGANGLIOSIDICI ATTE AL TRATTAMENTO DEL DANNO AL MIDOLLO SPINALE

摘要

Pharmaceutical compositions containing monosialoganglioside derivatives suitable for the treatment of spinal cord injury caused by hypoxic-ischaemic or traumatic events, in which said derivatives are selected from the group consisting of the inner ester (AGF2) and the methyl ester (AGF4) of the monosialoganglioside (GM1).